Nutrien Ltd. (NTR:TSX) Scotiabank cut the target to $141 from $152.50

STA Research
by: STA Research
Nutrien Ltd.

Scotiabank Capital maintained the Outperform on Nutrien Inc. to $141 from $152.50.

BMO Financial on Friday maintained the Outperform rating, and lowered the target to $115 from $125 per share, while Morningstar raised the target to $115 with a Hold rating. STA Research maintained their Hold rating and $85 target.

Nutrien Ltd Stock Analysis:

Based on the Nutrien Ltd stock forecasts from 14 analysts, the average analyst target price for Nutrien Ltd is CAD 119.23 over the next 12 months. Nutrien Ltd’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Nutrien Ltd is Bullish , which is based on 9 positive signals and 3 negative signals. At the last closing, Nutrien Ltd’s stock price was CAD 109.99Nutrien Ltd’s stock price has changed by +0.34% over the past week, +11.29% over the past month and +47.16% over the last year.

What we like:

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What we don’t like:

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Disclaimer

Stock Target Advisor is not a broker/dealer, investment advisor, or platform for making stock buying or selling decisions. Our goal is to democratize and simplify financial information through automated analysis, aggregation of stock information, and education to help investors with their research. No content on our site, blogs or newsletters constitutes – or should be understood as constituting – a recommendation to enter into any securities transactions or to engage in any of the investment strategies presented in our site content. We also cannot guarantee the accuracy of any information presented on our site and in our analysis.

Leave a Reply

Your email address will not be published.